From MarketBeat:



National Bank of Canada FI has reduced its holdings in Elanco Animal Health by 73.4% in the 3rd quarter, now owning 175,645 shares of the company’s stock. Other large investors have also modified their holdings of the company, with some increasing their stakes by a significant amount. Elanco Animal Health has a 1-year low of $7.88 and a 1-year high of $14.81, and has last posted earnings per share of $0.18. Wall Street analysts are forecasting growth and have recently commented on the stock, with a consensus rating of “Hold” and a consensus target price of $14.21.

Elanco Animal Health Incorporated is an animal health company that innovates, develops, manufactures, and markets products for pets and farm animals, and was reviewed by MarketBeat’s editorial team prior to publication. MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts, and has identified five stocks that top analysts are quietly recommending to their clients. If a company’s CEO, COO, and CFO were all selling shares of their stock, MarketBeat offers a free report.



Read more: National Bank of Canada FI Has $1.92 Million Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN)